Is there still a place for myeloablative regimen to transplant young adults with sickle cell disease?

To the editor: We have read with great interest the comprehensive and detailed review on hematopoietic stem cell transplantation (HSCT) for sickle cell disease (SCD) published by Hsieh et al in a recent issue of the journal.[1][1] As emphasized by the authors, allogeneic HSCT is currently the only